THRD
Third Harmonic Bio Inc.
NASDAQ: THRD · HEALTHCARE · BIOTECHNOLOGY
$5.38
+0.00% today
Updated 2026-04-29
Market cap
$242.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$5 – $6
Volume
—
Third Harmonic Bio Inc. (THRD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+45.9%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.0%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
+0.0%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-06 | $0.00 | +100.0% | $5.38 | $5.38 | +0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.18 | $0.00 | +100.0% | — | — |
| 2025-06-30 | $-0.23 | $0.00 | +100.0% | — | — |
| 2025-03-31 | $-0.27 | $-0.35 | -32.1% | — | — |
| 2024-12-31 | $-0.36 | $-0.30 | +15.5% | $48000.00 | -94.3% |
| 2024-09-30 | $-0.30 | $-0.33 | -10.3% | — | — |
| 2024-06-30 | $-0.25 | $-0.26 | -4.0% | — | — |
| 2024-03-31 | $-0.31 | $-0.20 | +35.5% | — | — |
| 2023-12-31 | $-0.31 | $-0.17 | +45.2% | $836000.00 | — |
| 2023-09-30 | $-0.27 | $-0.19 | +29.6% | — | — |
| 2023-06-30 | $-0.30 | $0.19 | +163.3% | — | — |
| 2023-03-31 | $-0.35 | $-0.81 | -131.4% | — | — |
| 2022-12-31 | $-0.47 | $-0.36 | +23.4% | — | — |
Frequently asked questions
Has Third Harmonic Bio Inc. beaten earnings estimates?
Third Harmonic Bio Inc. has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +45.9% over the last 4 quarters.
How does THRD stock react to earnings?
THRD stock has moved an average of +0.0% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.